Healthcare DIVE May 16, 2018
Tony Abraham

Dive Brief:

  • HHS Secretary Alex Azar underscored proposed changes made in President Donald Trump’s “American Patients First” blueprint in a speech to the American Enterprise Institute, where he defended against criticism that Trump dropped support of Medicare directly negotiating drug prices.
  • Azar argued that the free market is better equipped to drive down costs while preserving consumers’ right to choose what works for them.
  • Trump’s plan seeks to merge some parts of Medicare Part B into Part D, which the pharmaceutical industry has opposed. The secretary warned that if pharma doesn’t bring the administration “a plan for which drugs make sense to move from Part B to Part D, we’ll decide that for them.”
...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, HHS, Pharma, Pricing / Spending, Provider
Biden cracks down on junk health plans
White House issues federal agency policy on AI use, oversight
Administration finalizes rule limiting short-term, limited-duration insurance
White House Wants Chief AI Officers to Keep Federal AI Use Responsible
GOP plans for Medicaid cuts could face backlash

Share This Article